Credits: Canva
A recent study suggests that people who donate blood regularly may have genetic changes in their blood that could in fact reduce the risk of developing cancer. It is conducted by the researchers at the Francis Crick Institute, and the study has now provided new insights into how and why blood cancers develop. The study is published in the journal Blood and was conducted by the scientists from Heidelberg and the German Red Cross blood donation center. There is yet a need for further research to confirm these findings.
The researchers examined the blood of two groups of healthy male donors in their 60s:
The goal was to analyze genetic mutations in their blood and assess whether frequent donation had any impact on their genetic makeup.
As and when people age, their blood and other cells naturally develop mutations and some of them can also increase the risk of cancer. When anyone donates blood, his or her body compensates by producing new blood cells, which can influence the genetic diversity of stem cells in the bone marrow. The study also found that both groups had a similar number of mutations. For instance the frequent donors had 217 mutations, while the irregular donors had 212 mutations.
However, the nature of these mutations differed. In the frequent donors, 50% of the mutations were of a type not associated with a high risk of blood cancers, compared to only 30% in the irregular donors.
Further laboratory analysis showed that these specific mutations behaved differently from those linked to leukemia, a type of blood cancer. When human blood stem cells with these mutations were injected into mice, they were found to be highly effective at producing red blood cells, which is considered a positive outcome.
Dr. Hector Huerga Encabo, one of the study authors, emphasized that these mutations do not indicate an increased risk of leukemia. The findings suggest that regular blood donation may influence how stem cells evolve, but whether this translates into a lower cancer risk remains uncertain.
Read More: Who Can Donate Blood To Whom?
One notable disadvantage is the "healthy-donor effect"—because blood donors are often healthier than the general population, their lower cancer risk could be unrelated to blood donation.
Dominique Bonnet, senior researcher and head of a stem-cell laboratory at the Francis Crick Institute, stressed the need for larger studies with female volunteers to confirm the findings.
Despite ongoing research into potential health benefits for donors, the primary goal of blood donation remains saving lives. NHS Blood and Transplant emphasized that while the study is interesting, further research is required to draw firm conclusions. The organization also noted that blood supplies are currently critically low and encouraged eligible individuals to donate.
Also Read: How Long After a Tattoo or Piercing Can I Donate Blood?
Credits: Canva
Seychelles Chikungunya Virus Outbreak: The United States warned travelers to be careful if they plan to visit the Seychelles islands anytime soon as it is currently undergoing a chikungunya outbreak. As per the Centers for Disease Control and Prevention (CDC), a 'Level 2' advisory for the island has been issued and travelers have been asked to 'practice enhanced precautions' if they do plan to visit.
Chikungunya is a mosquito-borne viral disease transmitted primarily by Aedes aegypti and Aedes albopictus, the same mosquitoes that spread dengue fever. Symptoms typically appear three to seven days after a bite and include sudden fever, severe joint pain, headache, nausea, fatigue, and rash in about half of cases.
However, there are certain unique symptoms of chikungunya. For instance, unlike a Dengue fever, chikungunya leaves lingering effects along with joint pain and fatigue that lasts up to weeks.
While common symptoms like high fever often >102 degree F is common there are other symptoms too, which includes:
Chikungunya symptoms usually occur with in 3 to 7 days after a bite. However, the symptoms could often last long. While fever could subside in a day or two, chronic symptoms especially like joint pain and muscle pain could last for months. Weakness too could persist.
A Level 2 travel advisory has been issued, which means the travelers are expected to practice enhanced precautions as compared to a Level 1 advisory that only asks travelers to practice usual precautions.
In more serious cases, Level 3 advisory is issued that asks travelers to reconsider non-essential travel, whereas a Level 4 advisory asks travelers to avoid all travel.
Read: CDC Travel Advisory Issued For These Islands Amid Chikungunya Outbreak
As CDC issues travel advisory, here is what travelers are expected to do:
Credits: Canva
Why do some relationships feel effortless and magnetic, while others slowly unravel despite our best intentions? According to neuroscientist Andrew Huberman, the answers lie deep within our early childhood experiences and the intricate wiring of the brain.
In a recent episode of Huberman Lab titled “Essentials: The Science of Love, Desire & Attachment,” Huberman explores how biology and psychology work together to shape the way we connect, commit, and sometimes drift apart. What makes the conversation compelling is how it bridges hard science with very human emotions.
Huberman begins with a powerful idea: the way we love as adults often echoes how we were loved as children.
He refers to the landmark “Strange Situation” experiment by psychologist Mary Ainsworth. In this study, toddlers were briefly separated from their caregivers and then reunited. Researchers closely observed how the children reacted. Some felt secure and soothed upon return. Others were anxious, avoidant, or distressed.
These early attachment patterns, Huberman explains, frequently resurface in adult romantic relationships. A securely attached child may grow into a partner who trusts and communicates well. An anxious child may become someone who fears abandonment. An avoidant child may struggle with emotional closeness.
The hopeful part? These patterns are not destiny. Awareness allows change. Once people recognize their emotional blueprint, they can reshape it.
Romantic connection is not housed in a single “love center.” Instead, multiple brain regions activate in sequence to create desire, attraction, empathy, and long term bonding.
Huberman clears up a common myth about dopamine. Many people think of it as the pleasure chemical. In reality, it is more about motivation and pursuit. Dopamine fuels craving and drives us toward a person we find compelling. It is the chemical that makes you check your phone, wait for a message, or feel a rush at the thought of someone.
But desire alone does not sustain love.
For deeper attachment, empathy circuits come into play. The prefrontal cortex and the insula are especially important. The insula helps us sense our internal bodily state, a process known as interoception. It allows us to feel our own emotions while tuning into someone else’s. This shared emotional awareness strengthens bonds.
One of the most fascinating ideas Huberman discusses is what he calls “positive delusion.” For long term stability, the brain benefits from believing that your partner is uniquely special. This slight bias, almost a romantic illusion, reinforces commitment.
It is not about ignoring flaws. It is about genuinely feeling that this person, out of billions, holds a singular place in your emotional world. Biologically, this strengthens attachment pathways.
Huberman also references research from the Gottman Lab at the University of Washington. Decades of data reveal four behaviors that predict relationship breakdown: criticism, defensiveness, stonewalling, and contempt.
Stonewalling happens when one partner emotionally withdraws and stops responding. But the most toxic behavior is contempt. Researchers have described it as acid to a relationship because it corrodes trust and shuts down empathy. Once contempt takes root, the neural circuits that support connection begin to weaken.
In the end, love is both chemistry and choice. Our brains may set the stage, but awareness, empathy, and daily behavior determine whether attachment deepens or quietly falls away.
Credits: Canva
For decades, scientists believed the gradual loss of the Y chromosome in ageing men did not matter much. But a growing body of research now suggests otherwise. Studies show that losing the Y chromosome in blood and other tissues is linked to heart disease, cancer, Alzheimer’s disease and even shorter lifespan. The crux is simple but striking. As men age, many of their cells quietly lose the Y chromosome, and this loss may be shaping men’s health in ways we are only beginning to understand.
Men are born with one X and one Y chromosome. While the X carries hundreds of important genes, the Y is much smaller and contains just 51 protein coding genes. Because of this, scientists long assumed that losing the Y in some cells would not have serious consequences beyond reproduction.
However, newer genetic detection techniques tell a different story. Research shows that about 40 percent of men aged 60 have some cells that have lost the Y chromosome. By age 90, that number rises to 57 percent. Smoking and exposure to carcinogens appear to increase the likelihood of this loss.
This phenomenon, known as mosaic loss of Y, does not occur in every cell. Instead, it creates a patchwork in the body where some cells carry the Y chromosome and others do not. Once a cell loses the Y, its daughter cells also lack it. Interestingly, Y deficient cells seem to grow faster in laboratory settings, which may give them a competitive edge in tissues and even in tumors.
The Y chromosome has long been viewed as mainly responsible for male sex determination and sperm production. It is also uniquely vulnerable during cell division and can be accidentally left behind and lost. Since cells can survive without it, researchers assumed it had little impact on overall health.
Yet mounting evidence challenges that assumption. Several large studies have found strong associations between loss of the Y chromosome and serious health conditions in older men. A major German study reported that men over 60 with higher levels of Y loss had an increased risk of heart attacks. Other research links Y loss to kidney disease, certain cancers and poorer cancer outcomes.
There is also evidence connecting Y loss with neurodegenerative conditions. Studies have observed a much higher frequency of Y chromosome loss in men with Alzheimer’s disease. During the COVID pandemic, researchers noted that men with Y loss appeared to have worse outcomes, raising questions about its role in immune function.
Association does not automatically mean causation. It is possible that chronic illness or rapid cell turnover contributes to Y loss rather than the other way around. Some genetic studies suggest that susceptibility to losing the Y chromosome is partly inherited and tied to genes involved in cell cycle regulation and cancer risk.
However, animal research offers stronger clues. In one mouse study, scientists transplanted Y deficient blood cells into mice. The animals later developed age related problems, including weakened heart function and heart failure. This suggests the loss itself may directly contribute to disease.
So how can such a small chromosome have such wide ranging effects? While the Y carries relatively few genes, several of them are active in many tissues and help regulate gene activity. Some act as tumor suppressors. The Y also contains non coding genetic material that appears to influence how other genes function, including those involved in immune responses and blood cell development.
The full DNA sequence of the human Y chromosome was only completed recently. As researchers continue to decode its functions, the message for men’s health is becoming clearer. Ageing is not just about wrinkles or grey hair. At a microscopic level, the gradual disappearance of the Y chromosome may be quietly influencing heart health, brain health and cancer risk.
Understanding this process could open new doors for early detection, personalized risk assessment and targeted therapies that help men live longer and healthier lives.
© 2024 Bennett, Coleman & Company Limited